Sectors

ELV
Elevance Health, Inc.
395.35
120 x 393.10
120 x 395.60
bid
ask
-
1.36
0.34%
10:13 AM
timesize
Ytd 12.78%
1y 1.37%
392.98
day range
398.27
273.71
52 week range
412.96
Open 394.27 Prev Close 396.71 Low 392.98 High 398.27 Mkt Cap 85.94B
Vol 183.88K Avg Vol 1.92M EPS 23.60 P/E 16.77 Forward P/E 13.68
Beta 0.67 Short Ratio 2.83 Inst. Own 94.99% Dividend 6.88 Div Yield 1.75
Ex Div Date 06-10 Earning 07-16 50-d Avg 323.94 200-d Avg 329.24 1yr Est 388.95
Earning
Date For Estimate Reported Surprise surprise %
2026-04-22 2026-03 10.68 12.58 1.9 17.79%
2026-01-28 2025-12 3.11 3.33 0.22 7.07%
2025-10-21 2025-09 4.98 6.03 1.05 21.08%
2025-07-17 2025-06 9.16 8.84 -0.32 -3.49%
2025-04-22 2025-03 11.21 11.97 0.76 6.78%
2025-01-23 2024-12 3.8 3.84 0.04 1.05%
Upgrade / Downgrade
Date Firm Action From To
2026-04-29 B of A Securities Upgrade Neutral Buy
2026-04-28 JP Morgan Upgrade Overweight Overweight
2026-04-24 Barclays Upgrade Overweight Overweight
2026-04-24 Guggenheim Upgrade Buy Buy
2026-04-23 Evercore ISI Group Upgrade In-Line In-Line
2026-04-23 Baird Upgrade Neutral Neutral
Profile
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Insider Holder
Date Name Relation Quantity Description
2025-07-17 BOUDREAUX GAIL A KOZIARA Chief Executive Officer 151.08K Purchase
2026-03-01 BOUDREAUX GAIL KOZIARA Chief Executive Officer 169.31K Stock Award(Grant)
2025-05-13 DIXON ROBERT L JR Director 10.32K Stock Award(Grant)
2025-05-13 HAY LEWIS III Director 11.51K Stock Award(Grant)
2026-03-01 HAYTAIAN PETER D Officer 27.22K Stock Award(Grant)
2026-03-01 KAYE MARK Chief Financial Officer 32.04K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 19.89M 7.89B 9.16%
2026-03-30 Vanguard Capital Management LLC 14.35M 5.69B 6.61%
2025-12-30 State Street Corporation 10.34M 4.10B 4.76%
2025-12-30 Wellington Management Group, LLP 8.29M 3.29B 3.82%
2025-12-30 Price (T.Rowe) Associates Inc 7.45M 2.95B 3.43%
2026-03-30 Vanguard Portfolio Management LLC 6.36M 2.52B 2.93%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 6.99M 2.77B 3.22%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 5.60M 2.22B 2.58%
2026-01-30 VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund 3.07M 1.22B 1.41%
2026-01-30 First Eagle Funds-First Eagle Global Fund 2.84M 1.13B 1.31%
2026-03-30 iShares Trust-iShares Core S&P 500 ETF 2.84M 1.13B 1.31%
2026-03-30 Fidelity Concord Street Trust-Fidelity 500 Index Fund 2.82M 1.12B 1.30%
Dividend
Dividend Date
1.72 2026-06-10
1.72 2026-03-10
1.71 2025-12-05
1.71 2025-09-10
1.71 2025-06-10
1.71 2025-03-10
Split
Split Date
2 : 1 2005-06-01